Versuchen GOLD - Frei

ABB and B&R launch first fully integrated Machine-Centric Robotics solution

Express Pharma

|

February 01-15, 2020

Fully integrating ABB’s robots into its automation systems means that B&R will now be able to supply machine builders with machine automation and robotics from a single source

ABB and B&R launch first fully integrated Machine-Centric Robotics solution

B&R, a unit of ABB’s Robotics and Discrete Automation business, announced the integration of ABB robots into its automation portfolio. With the ability to offer unprecedented levels of machine flexibility and precision, merging robotics with machine control into one unified architecture will enable manufacturers to embrace the trend of mass customization and optimize their lot size one processes.

Fully integrating ABB’s robots into its automation systems means that B&R will now be able to supply machine builders with machine automation and robotics from a single source. Machine builders will be able to buy their robots from B&R along with all their control, I/O and drive components.

“The integration of ABB’s robot fleet into the B&R portfolio makes us a true one-stop-shop. We are the only company to offer industrial automation customers the entire range of integrated hardware and software solutions around control, actuation, robotics, sensing and analytics, and electrification. Our strength lies in our ability to combine ABB and B&R products into one solution, supported by our deep application expertise. This will help manufacturers increase their flexibility, at all levels including machines, to support shorter product cycles and to make much smaller lots of greater variety,” said Sami Atiya, President of ABB’s Robotics and Discrete Automation business.

WEITERE GESCHICHTEN VON Express Pharma

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Translate

Share

-
+

Change font size